255 related articles for article (PubMed ID: 32419532)
1. A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia.
Capria S; Molica M; Mohamed S; Bianchi S; Moleti ML; Trisolini SM; Chiaretti S; Testi AM
Expert Rev Hematol; 2020 Jul; 13(7):755-769. PubMed ID: 32419532
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute lymphoblastic leukemia.
Pui CH; Evans WE
N Engl J Med; 2006 Jan; 354(2):166-78. PubMed ID: 16407512
[No Abstract] [Full Text] [Related]
3. Recent Advances in the Management of Acute Lymphoblastic Leukaemia.
Hodby KA; Marks DI
Curr Treat Options Oncol; 2020 Feb; 21(3):23. PubMed ID: 32095902
[TBL] [Abstract][Full Text] [Related]
4. Progress and challenges in the therapy of adult acute lymphoblastic leukemia.
Kebriaei P; Larson RA
Curr Opin Hematol; 2003 Jul; 10(4):284-9. PubMed ID: 12799534
[TBL] [Abstract][Full Text] [Related]
5. TP53 in adult acute lymphoblastic leukemia.
Salmoiraghi S; Rambaldi A; Spinelli O
Leuk Lymphoma; 2018 Apr; 59(4):778-789. PubMed ID: 28679301
[TBL] [Abstract][Full Text] [Related]
6. The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).
Escherich G; Tröger A; Göbel U; Graubner U; Pekrun A; Jorch N; Kaspers G; Zimmermann M; zur Stadt U; Kazemier K; Pieters R; Den Boer ML; Horstmann M; Janka GE;
Haematologica; 2011 Jun; 96(6):854-62. PubMed ID: 21330320
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy.
Pui CH; Pei D; Raimondi SC; Coustan-Smith E; Jeha S; Cheng C; Bowman WP; Sandlund JT; Ribeiro RC; Rubnitz JE; Inaba H; Gruber TA; Leung WH; Yang JJ; Downing JR; Evans WE; Relling MV; Campana D
Leukemia; 2017 Feb; 31(2):333-339. PubMed ID: 27560110
[TBL] [Abstract][Full Text] [Related]
8. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.
Escherich G; Horstmann MA; Zimmermann M; Janka-Schaub GE;
Leukemia; 2010 Feb; 24(2):298-308. PubMed ID: 20016530
[TBL] [Abstract][Full Text] [Related]
9. Acute lymphoblastic leukemia.
Chan KW
Curr Probl Pediatr Adolesc Health Care; 2002 Feb; 32(2):40-9. PubMed ID: 11951089
[TBL] [Abstract][Full Text] [Related]
10. Newly diagnosed childhood acute lymphoblastic leukemia: update on prognostic factors and treatment.
Silverman LB; Sallan SE
Curr Opin Hematol; 2003 Jul; 10(4):290-6. PubMed ID: 12799535
[TBL] [Abstract][Full Text] [Related]
11. Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity.
Schramm F; Zur Stadt U; Zimmermann M; Jorch N; Pekrun A; Borkhardt A; Imschweiler T; Christiansen H; Faber J; Schmid I; Feuchtinger T; Beron G; den Boer ML; Pieters R; Horstmann MA; Janka-Schaub GE; Escherich G
Blood Adv; 2019 Nov; 3(22):3688-3699. PubMed ID: 31765480
[TBL] [Abstract][Full Text] [Related]
12. [Acute leukemia in adults].
Eigendorff E; Hochhaus A
Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
[TBL] [Abstract][Full Text] [Related]
13. Management of acute lymphoblastic leukemia in young adults.
Muffly LS; Reizine N; Stock W
Clin Adv Hematol Oncol; 2018 Feb; 16(2):138-146. PubMed ID: 29741514
[TBL] [Abstract][Full Text] [Related]
14. Recent approaches in acute lymphoblastic leukemia in adults.
Gökbuget N; Hoelzer D
Rev Clin Exp Hematol; 2002 Jun; 6(2):114-41; discussion 200-2. PubMed ID: 12196212
[TBL] [Abstract][Full Text] [Related]
15. Therapy of the newly diagnosed adult with acute lymphoblastic leukemia.
Hoelzer DF
Hematol Oncol Clin North Am; 1993 Feb; 7(1):139-60. PubMed ID: 8449856
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia.
Short NJ; Kantarjian HM; Jabbour EJ; O'Brien SM; Faderl S; Burger JA; Garris R; Qiao W; Huang X; Jain N; Konopleva M; Kadia TM; Daver N; Borthakur G; Cortes JE; Ravandi F
Am J Hematol; 2016 Jun; 91(4):385-9. PubMed ID: 26800008
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes of Modified St Jude Children's Research Hospital Total Therapy XIIIB and XV Protocols for Thai Children With Acute Lymphoblastic Leukemia.
Surapolchai P; Anurathapan U; Sermcheep A; Pakakasama S; Sirachainan N; Songdej D; Pongpitcha P; Hongeng S
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):497-505. PubMed ID: 31103474
[TBL] [Abstract][Full Text] [Related]
18. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: a broader range of options, improved outcomes, and more therapeutic dilemmas.
Fielding AK
Am Soc Clin Oncol Educ Book; 2015; ():e352-9. PubMed ID: 25993196
[TBL] [Abstract][Full Text] [Related]
20. ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
Henze G; v Stackelberg A; Eckert C
Klin Padiatr; 2013 May; 225 Suppl 1():S73-8. PubMed ID: 23700062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
